# OnCo record paper-exam-cabozantinib-mtc-elisei-jco-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-exam-cabozantinib-mtc-elisei-jco-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-exam-cabozantinib-mtc-elisei-jco-2013" ;
  schema:name "EXAM: cabozantinib in progressive medullary thyroid cancer"@en ;
  schema:description "Cabozantinib, a kinase inhibitor blocking RET, MET and VEGF receptors, delayed progression by more than seven months compared with placebo in progressive medullary thyroid cancer, at the cost of considerable toxicity."@en ;
  schema:url <https://onco.cc/key-papers/paper-exam-cabozantinib-mtc-elisei-jco-2013/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2012.48.4659>, <https://pubmed.ncbi.nlm.nih.gov/24002501/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2012.48.4659> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Elisei R, Schlumberger MJ, Müller SP, et al." ;
  onco:cancers <https://onco.cc/cancers/medullary-thyroid-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cabozantinib/> ;
  onco:trials <https://onco.cc/trials/exam/> ;
  onco:journals <https://onco.cc/journals/jco/> .